bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

Go back to bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
(NASDAQ: BIAF) Delayed: 9.51 -5.76 (37.72%)
Previous Close $15.27    52 Week High
Open $10.63    52 Week Low
Day High $10.63    P/E N/A 
Day Low $8.36    EPS
Volume 2,229,204       

(NASDAQ: BIAFW) Delayed: 0.60 -0.1 (14.29%)
Previous Close $0.70    52 Week High
Open $0.98    52 Week Low
Day High $0.98    P/E N/A 
Day Low $0.55    EPS
Volume 47,716